Chairman, SSAT

30 plus years of leadership experience in drug discovery research at Parke-Davis (now Pfizer), Atherogenics, Reddy labs, Kareus therapeutics. Out-licensed several candidates to major biopharma in Europe and USA. Received PhD from Memorial University, Canada and post-doctoral training at University of Columbia, USA.

A successful and serial entrepreneur founded Somahlution, Nucleonics in the past. Currently CEO of Prodigy. Served as CTO at Pfizer and headed Wyeth/Lederle Vaccine. PhD from Memorial University, Canada and postdoctorial training from Fox Chase Cancer Institute, USA.

Nearly 30 years of leadership experience in drug discovery and regulatory drug development research in major bio pharma companies including Wyeth (Pfizer), Purdue Pharma, JNJ and Shire and CROs including Sai Life and Advinus. Supported several INDs and NDAs submissions to US-FDA. Supported at least five to six NCE molecules which are currently on the market. Received PhD from Memorial University, Canada and post-doctoral training at University of Colorado at Boulder and University of California, Berkeley, USA.

A successful serial entrepreneur. Managing Director of Metahelix Life Sciences, a Tata enterprise. Metahelix is based in Bangalore, India, and is focused on crop improvement, using all the modern tools of plant genetic manipulation.Narayanan is trained as a plant breeder and molecular biologist. He graduated with a Ph.d. in plant breeding and genetics from the Tamil Nadu Agricultural University at Coimbatore, India. He later on carried out post-doctoral research at the department of biological sciences, Stanford University under a Rockefeller Foundation fellowship.Returning to India, he started his career as a scientist at the Spic Science Foundation, Chennai and later moved on to lead the crop transformation and functional genomics programme at the Monsanto Research Centre located within the Indian Institute of Science, Bangalore. In 2001, he along with four other scientist colleagues founded Metahelix Life Sciences and has since been leading its operations.Narayanan is a member of several committees and advisory bodies including several scientific task forces on “agricultural biotechnology”of the DBT, Government of India, and the “Vision Group” on Biotechnology set up by the Karnataka government.

Currently an independent consultant. Dr. Mukherjee served as senior expert pharmacologist at FDA for 27 years reviewing regulatory documents related IND and NDA submissions. He received his PhD from All India Medical Institute of India.

Advisor, Nutritional Products

Successful entrepreneur foundere and director of Atrimed for 17 years. He developed many herbal health products sold in global markets. He received his MD in Ayurveda rrom Bangalore University.